Wendy Dixon

Wendy Dixon

President chez
Great Meadow Consulting LLC

Fortune : - $ au 31/05/2026

70 ans
Health Technology
Consumer Services
Finance

Profil

Wendy L.
Dixon
is currently Independent Director at Alkermes, Inc. since 2011, Director at Special Equestrians, Inc., and President of Great Meadow Consulting LLC since 2009.
Former roles include Chairman at Sesen Bio, Inc. from 2016 to 2020; Director at DENTSPLY International, Inc. from 2005 to 2010; Independent Director at Incyte Corp.
from 2011 to 2022; Independent Director at Orexigen Therapeutics, Inc. from 2010 to 2016; Independent Director at Furiex Pharmaceuticals, Inc. from 2012 to 2014; Independent Director at Arvinas, Inc. from 2020 to 2024; Independent Director at bluebird bio, Inc. from 2013 to 2021; Independent Director at Ardea Biosciences, Inc. from 2011 to 2012; Director at Edimer Pharmaceuticals, Inc.; Independent Director at Iovance Biotherapeutics, Inc. from 2022 to 2023; Independent Director at Voyager Therapeutics, Inc. from 2017 to 2021; Independent Director at Black Diamond Therapeutics, Inc. from 2022 to 2024; Independent Director at Alkermes Plc from 2011 to 2022; Independent Director at Zevra Therapeutics, Inc. from 2023 to 2025; President & Chief Marketing Officer at Bristol Myers Squibb Co. from 2001 to 2009; Principal at Centocor, Inc.; Senior Vice President-Marketing at Merck & Co., Inc. from 1996 to 2001; Principal at Osteotech, Inc.; Principal at West Pharmaceutical Services, Inc.; Senior Advisor at The Monitor Group, Inc.; and Principal at Smithkline & French Laboratories US, Inc. Education includes undergraduate, graduate, and doctorate degrees from the University of Cambridge.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/05/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Wendy Dixon

SociétésPosteDébut
Directeur/Membre du Conseil 16/09/2011
Directeur/Membre du Conseil -
President 01/07/2009

Anciens postes connus de Wendy Dixon

SociétésPosteFin
ZEVRA THERAPEUTICS, INC. Directeur/Membre du Conseil 02/12/2025
ARVINAS, INC. Directeur/Membre du Conseil 01/05/2024
BLACK DIAMOND THERAPEUTICS, INC. Directeur/Membre du Conseil 10/04/2024
IOVANCE BIOTHERAPEUTICS, INC. Directeur/Membre du Conseil 06/06/2023
INCYTE CORPORATION Directeur/Membre du Conseil 14/06/2022
Voir l'expérience en détail de Wendy Dixon

Formation de Wendy Dixon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

74

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Smithkline & French Laboratories US, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Wendy Dixon
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇